192 related articles for article (PubMed ID: 32635192)
41. SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung.
Underwood DC; Osborn RR; Bochnowicz S; Webb EF; Rieman DJ; Lee JC; Romanic AM; Adams JL; Hay DW; Griswold DE
Am J Physiol Lung Cell Mol Physiol; 2000 Nov; 279(5):L895-902. PubMed ID: 11053025
[TBL] [Abstract][Full Text] [Related]
42. The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer.
Park KS; Yang H; Choi J; Seo S; Kim D; Lee CH; Jeon H; Kim SW; Lee DH
Cancer Lett; 2017 Oct; 406():47-53. PubMed ID: 28797845
[TBL] [Abstract][Full Text] [Related]
43. The HSP90 inhibitor, NVP-AUY922, sensitizes KRAS-mutant non-small cell lung cancer with intrinsic resistance to MEK inhibitor, trametinib.
Park KS; Oh B; Lee MH; Nam KY; Jin HR; Yang H; Choi J; Kim SW; Lee DH
Cancer Lett; 2016 Mar; 372(1):75-81. PubMed ID: 26723875
[TBL] [Abstract][Full Text] [Related]
44. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
45. JAK1-dependent transphosphorylation of JAK2 limits the antifibrotic effects of selective JAK2 inhibitors on long-term treatment.
Zhang Y; Liang R; Chen CW; Mallano T; Dees C; Distler A; Reich A; Bergmann C; Ramming A; Gelse K; Mielenz D; Distler O; Schett G; Distler JHW
Ann Rheum Dis; 2017 Aug; 76(8):1467-1475. PubMed ID: 28478401
[TBL] [Abstract][Full Text] [Related]
46. Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922.
Kühnel A; Schilling D; Combs SE; Haller B; Schwab M; Multhoff G
Cells; 2019 Sep; 8(10):. PubMed ID: 31569342
[TBL] [Abstract][Full Text] [Related]
47. Effects of IS-741, a synthetic anti-inflammatory agent, on bleomycin-induced lung injury in mice.
Shimaoka Y; Tajima S; Fujimori F; Yamabayashi C; Moriyama H; Terada M; Takada T; Suzuki E; Bando M; Sugiyama Y; Narita I
Lung; 2009; 187(5):331-9. PubMed ID: 19672658
[TBL] [Abstract][Full Text] [Related]
48. Essential role of stem cell factor-c-Kit signalling pathway in bleomycin-induced pulmonary fibrosis.
Ding L; Dolgachev V; Wu Z; Liu T; Nakashima T; Wu Z; Ullenbruch M; Lukacs NW; Chen Z; Phan SH
J Pathol; 2013 Jun; 230(2):205-14. PubMed ID: 23401096
[TBL] [Abstract][Full Text] [Related]
49. HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2.
Yang H; Lee MH; Park I; Jeon H; Choi J; Seo S; Kim SW; Koh GY; Park KS; Lee DH
Cancer Lett; 2017 Dec; 411():19-26. PubMed ID: 28987383
[TBL] [Abstract][Full Text] [Related]
50. TGFβ signaling in lung epithelium regulates bleomycin-induced alveolar injury and fibroblast recruitment.
Degryse AL; Tanjore H; Xu XC; Polosukhin VV; Jones BR; Boomershine CS; Ortiz C; Sherrill TP; McMahon FB; Gleaves LA; Blackwell TS; Lawson WE
Am J Physiol Lung Cell Mol Physiol; 2011 Jun; 300(6):L887-97. PubMed ID: 21441353
[TBL] [Abstract][Full Text] [Related]
51. Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis.
Liu Q; Jiang JX; Liu YN; Ge LT; Guan Y; Zhao W; Jia YL; Dong XW; Sun Y; Xie QM
Toxicol Lett; 2017 May; 273():1-9. PubMed ID: 28300665
[TBL] [Abstract][Full Text] [Related]
52. Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis.
Lucarini L; Pini A; Rosa AC; Lanzi C; Durante M; Chazot PL; Krief S; Schreeb A; Stark H; Masini E
Pharmacol Res; 2016 Sep; 111():740-748. PubMed ID: 27475884
[TBL] [Abstract][Full Text] [Related]
53. Administration of a specific inhibitor of neutrophil elastase attenuates pulmonary fibrosis after acute lung injury in mice.
Fujino N; Kubo H; Suzuki T; He M; Suzuki T; Yamada M; Takahashi T; Ota C; Yamaya M
Exp Lung Res; 2012 Feb; 38(1):28-36. PubMed ID: 22148910
[TBL] [Abstract][Full Text] [Related]
54. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.
Kim S; Lim JH; Woo CH
Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924
[TBL] [Abstract][Full Text] [Related]
55. Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Inhibitor as a Novel Therapeutic Tool for Lung Injury.
Fusco R; Siracusa R; D'Amico R; Cordaro M; Genovese T; Gugliandolo E; Peritore AF; Crupi R; Di Paola R; Cuzzocrea S; Impellizzeri D
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092214
[TBL] [Abstract][Full Text] [Related]
56. Human airway trypsin-like protease exerts potent, antifibrotic action in pulmonary fibrosis.
Menou A; Flajolet P; Duitman J; Justet A; Moog S; Jaillet M; Tabèze L; Solhonne B; Garnier M; Mal H; Mordant P; Castier Y; Cazes A; Sallenave JM; Mailleux AA; Crestani B
FASEB J; 2018 Mar; 32(3):1250-1264. PubMed ID: 29122847
[TBL] [Abstract][Full Text] [Related]
57. Altered expression of tight junction molecules in alveolar septa in lung injury and fibrosis.
Ohta H; Chiba S; Ebina M; Furuse M; Nukiwa T
Am J Physiol Lung Cell Mol Physiol; 2012 Jan; 302(2):L193-205. PubMed ID: 22003091
[TBL] [Abstract][Full Text] [Related]
58. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
59. Thymosin β4 protects C57BL/6 mice from bleomycin-induced damage in the lung.
Conte E; Genovese T; Gili E; Esposito E; Iemmolo M; Fruciano M; Fagone E; Pistorio MP; Crimi N; Cuzzocrea S; Vancheri C
Eur J Clin Invest; 2013 Mar; 43(3):309-15. PubMed ID: 23320620
[TBL] [Abstract][Full Text] [Related]
60. Thymosin β4 reduces IL-17-producing cells and IL-17 expression, and protects lungs from damage in bleomycin-treated mice.
Conte E; Iemmolo M; Fagone E; Gili E; Fruciano M; Genovese T; Esposito E; Cuzzocrea S; Vancheri C
Immunobiology; 2014 Jun; 219(6):425-31. PubMed ID: 24613476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
